SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,330.80 -180.24
(-0.36%)

Dow Jones

7,129.46 -29.44
(-0.41%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

93.75 0.31
(0.34%)

EUR-INR

109.98 0.10
(0.09%)

GBP-INR

126.66 0.42
(0.33%)

JPY-INR

0.59 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ICICI Bank Ltd

Industry : Banks - Private Sector

BSE Code

ISIN Demat

Book Value()

532174

INE090A01021

461.8759172

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ICICIBANK

19.26

965715.16

EPS(TTM)

Face Value()

Div & Yield %

69.98

0.89

Back

Medicamen Biotech consolidated net profit rises 82.88% in the September 2025 quarter

Nov 15,2025

Net profit of Medicamen Biotech rose 82.88% to Rs 2.67 crore in the quarter ended September 2025 as against Rs 1.46 crore during the previous quarter ended September 2024. Sales rose 5.43% to Rs 47.17 crore in the quarter ended September 2025 as against Rs 44.74 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	47.17	44.74	5
OPM %	10.94	11.87	-
PBDT	4.54	4.56	0
PBT	2.68	1.96	37
NP	2.67	1.46	83

76,664.21 -999.79 ( -1.29%)

49,330.80 -180.24 (-0.36%)

7,129.46 -29.44 (-0.41%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

93.75 0.31 (0.34%)

109.98 0.10 (0.09%)

126.66 0.42 (0.33%)

0.59 0.00 (0.23%)